| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 82486 |
降冰片烯二酸酐(XMNA) |
265 |
h |
2024-11-29 |
| 82487 |
5-降冰片烯-2,3-二羧酸二甲酯(DCNM) |
139 |
h |
2024-11-29 |
| 82488 |
5-降冰片烯-2-亚甲基-(6-溴己基)醚(NB-O-Br) |
149 |
h |
2024-11-29 |
| 82489 |
N-环庚基降冰片烯酰亚胺(CHepNDI) |
111 |
h |
2024-11-29 |
| 82490 |
5-降冰片烯-2-甲醇(NB-CH2OH) |
143 |
h |
2024-11-29 |
| 82491 |
Tz-BODIPY-MOR；氟化硼二吡咯-四嗪靶向溶酶体 |
135 |
|
2024-11-29 |
| 82492 |
5-降冰片烯-2-甲醛 |
134 |
h |
2024-11-29 |
| 82493 |
侧链双键的降冰片烯衍生物(ENB) |
202 |
h |
2024-11-29 |
| 82494 |
降冰片烯基三氟乙酯(NF) |
208 |
h |
2024-11-29 |
| 82495 |
2375774-54-0，Pomalidomide-C6-O-C5-O-C4-COOH |
133 |
kx |
2024-11-29 |
| 82496 |
3,6-二-2-吡啶基-1,2,4,5-四嗪 |
133 |
WYQ |
2024-11-29 |
| 82497 |
钯芳基降冰片烯五元环(ANP) |
149 |
h |
2024-11-29 |
| 82498 |
（2-氨基乙基）-吗啉基团偶联3-（吡啶-3-基）-6-氨基乙基-1,2,4,5-四嗪偶联（LysoTz） |
120 |
WYQ |
2024-11-29 |
| 82499 |
降冰片烯羧酸甲酯聚合物(P(exo-MeNB) |
105 |
h |
2024-11-29 |
| 82500 |
1578249-76-9，Mal-C6-α-Amanitin |
86 |
kx |
2024-11-29 |
| 82501 |
降冰片烯二酸酐-马来酰亚胺基七异丁基聚倍半硅氧烷交替共聚物 poly(MIPOSS-alt-NA) |
303 |
h |
2024-11-29 |
| 82502 |
5-丁氧基亚甲基-2-降冰片烯,双-(β-酮萘胺)镍(Ⅱ)/B(C6F5)3 |
123 |
h |
2024-11-29 |
| 82503 |
CAS:2921619-48-7；DOTA-方酸-PEG4(丙酸)-ONCOFAP |
160 |
zcy |
2024-11-29 |
| 82504 |
萘酰亚胺修饰聚降冰片烯共聚物P-NB-NA-PEG |
94 |
h |
2024-11-29 |
| 82505 |
聚乙叉降冰片烯二乙烯基联苯共聚物 |
157 |
h |
2024-11-29 |
| 82506 |
ROPARGYL-DOTA-TRIS(TBU)ESTER；基于NOTADOTA定制和偶联 |
128 |
zcy |
2024-11-29 |
| 82507 |
降冰片烯官能化聚丙烯酸叔丁酯(NB-PtBA) |
159 |
h |
2024-11-29 |
| 82508 |
聚降冰片烯纳米纤维(PNB) |
251 |
h |
2024-11-29 |
| 82509 |
TRI-TERT-BUTYL 1,4,7,10-TETRAAZACYCLODOD；三叔丁基-1,4,7,10-四氮杂环十二烷 |
133 |
zcy |
2024-11-29 |
| 82510 |
DOTA-3-酪氨酰基-奥曲肽（DOTA-3-Tyr-Octreotide） |
79 |
zcy |
2024-11-29 |
| 82511 |
94885-02-6， C6 NBD Ceramide |
147 |
kx |
2024-11-29 |
| 82512 |
DOTA-tris(TBE)-amido dPEG (R)11-Maleimide；基于NOTADOTA定制和偶联 |
152 |
zcy |
2024-11-29 |
| 82513 |
479081-06-6 , DOTA-(COOt-Bu)3-NHFmoc-Lys |
180 |
wyh |
2024-11-29 |
| 82514 |
DOTA-octreotide |
89 |
wyh |
2024-11-29 |
| 82515 |
CAS:127985-74-4 ，DOTA-p-NCS-Bn ，多肽标记的双功能螯合剂 |
222 |
wyh |
2024-11-29 |
| 82516 |
N-(2-溴代异丁酰溴基)-顺-5-降冰片烯-外-2,3-二甲酰亚胺(exo-BNDI) |
160 |
h |
2024-11-29 |
| 82517 |
cyclo(RGDFK(DOTA)) |
114 |
wyh |
2024-11-29 |
| 82518 |
DOTA-tris(acid)-amido-dPEG (R)24-amido-dPEG (R)24-DSPE 定制 |
165 |
zcy |
2024-11-29 |
| 82519 |
Lu-DOTA-TATE ；镥-大环配体-TATE多肽 |
134 |
wyh |
2024-11-29 |
| 82520 |
11,12-二脱氢-ε-氧代二苯并[b,f]氮杂环辛-5(6H)-己酸，DBCO-C6-acid |
127 |
kx |
2024-11-29 |
| 82521 |
降冰片烯改性聚乙烯醇(PVA) |
200 |
h |
2024-11-29 |
| 82522 |
DOTA-PEG-CPP ， DOTA-聚乙二醇-酪蛋白磷酸肽 |
152 |
wyh |
2024-11-29 |
| 82523 |
乙酰基保护的降冰片烯含异类糖单体NBManGluOAc |
128 |
h |
2024-11-29 |
| 82524 |
降冰片二烯二酸单甲酯(NBD-COOH) |
231 |
h |
2024-11-29 |
| 82525 |
DOTA-E「cyclo(RGDfK)2的结构组成 |
171 |
wyh |
2024-11-29 |
| 82526 |
Ho-p-SCN-Bn-DOTA；2126179-28-8；基于NOTADOTA定制和偶联 |
97 |
zcy |
2024-11-29 |
| 82527 |
十八烷基-聚乙二醇-巯基吡啶 OPSS-PEG-C18 |
93 |
zyl |
2024-11-29 |
| 82528 |
DOTA-(Tyr3)-Octreotate，大环配体修饰多肽 |
103 |
wyh |
2024-11-29 |
| 82529 |
(S,R,S)-AHPC-Me-C6-NH2，CAS号：2411422-49-4 |
86 |
zyl |
2024-11-29 |
| 82530 |
4-氨基丁基-DOTA（4-Aminobutyl-DOTA）；753421-63-5 |
139 |
zcy |
2024-11-29 |
齐岳微信公众号
官方微信
库存查询